| 3US5 
   
  |  | 
| 2OX1 
   
  | | Archaeal Dehydroquinase |  | Descriptor: | 3-dehydroquinate dehydratase, GLYCEROL |  | Authors: | Gallagher, D.T,  Smith, N.N. |  | Deposit date: | 2007-02-19 |  | Release date: | 2008-02-19 |  | Last modified: | 2024-02-21 |  | Method: | X-RAY DIFFRACTION (2.33 Å) |  | Cite: | Structure and lability of archaeal dehydroquinase. Acta Crystallogr.,Sect.F, 64, 2008
 
 | 
 | 
| 8ITL 
   
  | | Cryo-EM structure of GIPR splice variant 1 (SV1) in complex with Gs protein |  | Descriptor: | Gastric inhibitory polypeptide receptor, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, ... |  | Authors: | Zhao, F.H,  Hang, K.N,  Zhou, Q.T,  Shao, L.J,  Li, H,  Li, W.Z,  Lin, S,  Dai, A.T,  Cai, X.Q,  Liu, Y.Y,  Xu, Y.N,  Feng, W.B,  Yang, D.H,  Wang, M.W. |  | Deposit date: | 2023-03-22 |  | Release date: | 2023-10-18 |  | Last modified: | 2025-07-16 |  | Method: | ELECTRON MICROSCOPY (3.23 Å) |  | Cite: | Molecular basis of signal transduction mediated by the human GIPR splice variants. Proc.Natl.Acad.Sci.USA, 120, 2023
 
 | 
 | 
| 1ZO0 
   
  |  | 
| 3EJS 
   
  | | Golgi alpha-Mannosidase II in complex with 5-substituted swainsonine analog: (5S)-5-[2'-(4-tert-butylphenyl)ethyl]-swainsonine |  | Descriptor: | (1S,2R,5S,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol, (4R)-2-METHYLPENTANE-2,4-DIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... |  | Authors: | Kuntz, D.A,  Shea, K,  Rose, D.R. |  | Deposit date: | 2008-09-18 |  | Release date: | 2009-10-13 |  | Last modified: | 2024-11-20 |  | Method: | X-RAY DIFFRACTION (1.35 Å) |  | Cite: | Structural Investigation of the Binding of 5-Substituted Swainsonine Analogues to Golgi alpha-Mannosidase II. Chembiochem, 11, 2010
 
 | 
 | 
| 7A17 
   
  | | Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody |  | Descriptor: | (2R)-3-{[(R)-{[(1S,2S,3R,4S,5S,6S)-2,6-dihydroxy-3,4,5-tris(phosphonooxy)cyclohexyl]oxy}(hydroxy)phosphoryl]oxy}propane -1,2-diyl dioctanoate, GLYCEROL, Isoform 2 of Synaptojanin-1, ... |  | Authors: | Paesmans, J,  Galicia, C,  Martin, E,  Versees, W. |  | Deposit date: | 2020-08-12 |  | Release date: | 2020-12-30 |  | Last modified: | 2024-10-23 |  | Method: | X-RAY DIFFRACTION (2.73 Å) |  | Cite: | A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations. Elife, 9, 2020
 
 | 
 | 
| 8PIF 
   
  | | Fragment 12 in complex with KLHDC2 |  | Descriptor: | 1,2-ETHANEDIOL, 2-(furan-3-yl)ethanoic acid, Kelch domain-containing protein 2 |  | Authors: | Boettcher, J,  Mayer, M. |  | Deposit date: | 2023-06-21 |  | Release date: | 2023-07-12 |  | Last modified: | 2024-06-19 |  | Method: | X-RAY DIFFRACTION (1.782 Å) |  | Cite: | KLHDC2 - The Next Level To Be Published
 
 | 
 | 
| 3E8S 
   
  |  | 
| 6CYU 
   
  | | Crystal structure of CTX-M-14 S70G/N106S/D240G beta-lactamase in complex with hydrolyzed cefotaxime |  | Descriptor: | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}(carboxy)methyl]-5-methylidene-5,6-dihydro -2H-1,3-thiazine-4-carboxylic acid, Beta-lactamase |  | Authors: | Patel, M.P,  Hu, L,  Sankaran, B,  Brown, C,  Prasad, B.V.V,  Palzkill, T. |  | Deposit date: | 2018-04-06 |  | Release date: | 2018-10-10 |  | Last modified: | 2023-10-04 |  | Method: | X-RAY DIFFRACTION (1.82 Å) |  | Cite: | Synergistic effects of functionally distinct substitutions in beta-lactamase variants shed light on the evolution of bacterial drug resistance. J. Biol. Chem., 293, 2018
 
 | 
 | 
| 8PFY 
   
  |  | 
| 7RWF 
   
  | | Crystal structure of CDK2 in complex with TW8672 |  | Descriptor: | 1,2-ETHANEDIOL, 2-{[2-(1H-indol-3-yl)ethyl]amino}-5-nitrobenzoic acid, Cyclin-dependent kinase 2 |  | Authors: | Sun, L,  Schonbrunn, E. |  | Deposit date: | 2021-08-19 |  | Release date: | 2022-08-24 |  | Last modified: | 2023-10-25 |  | Method: | X-RAY DIFFRACTION (1.5 Å) |  | Cite: | Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding. Nat Commun, 14, 2023
 
 | 
 | 
| 5LRA 
   
  | | Plastidial phosphorylase PhoI from barley in complex with maltotetraose |  | Descriptor: | Alpha-1,4 glucan phosphorylase, PYRIDOXAL-5'-PHOSPHATE, alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose, ... |  | Authors: | Cuesta-Seijo, J.A,  Ruzanski, C,  Krucewicz, K,  Palcic, M.M. |  | Deposit date: | 2016-08-18 |  | Release date: | 2017-05-03 |  | Last modified: | 2024-01-10 |  | Method: | X-RAY DIFFRACTION (3 Å) |  | Cite: | Functional and structural characterization of plastidic starch phosphorylase during barley endosperm development. PLoS ONE, 12, 2017
 
 | 
 | 
| 3M6H 
   
  | | Crystal Structure of Post-isomerized Ertapenem Covalent Adduct with TB B-lactamase |  | Descriptor: | (2S,3R,4S)-4-({(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl}sulfanyl)-2-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid, Beta-lactamase, PHOSPHATE ION |  | Authors: | Tremblay, L.W. |  | Deposit date: | 2010-03-15 |  | Release date: | 2010-04-14 |  | Last modified: | 2024-11-06 |  | Method: | X-RAY DIFFRACTION (1.994 Å) |  | Cite: | Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem. Biochemistry, 49, 2010
 
 | 
 | 
| 7RXO 
   
  | | Crystal structure of CDK2 liganded with compound WN333 |  | Descriptor: | 1,2-ETHANEDIOL, 2-{[2-(1H-indol-3-yl)ethyl]amino}-5-(methoxycarbonyl)benzoic acid, Cyclin-dependent kinase 2 |  | Authors: | Sun, L,  Schonbrunn, E. |  | Deposit date: | 2021-08-23 |  | Release date: | 2022-08-31 |  | Last modified: | 2023-10-25 |  | Method: | X-RAY DIFFRACTION (1.38 Å) |  | Cite: | Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice. J.Med.Chem., 66, 2023
 
 | 
 | 
| 9GGM 
   
  | | Cryo-EM structure of KBTBD4 P313PRR mutant-HDAC2 2:2 complex |  | Descriptor: | Histone deacetylase 2, Isoform 1 of Kelch repeat and BTB domain-containing protein 4, ZINC ION |  | Authors: | Chen, Z,  Chi, G,  Pike, A.C.W,  Montes, B,  Bullock, A.N. |  | Deposit date: | 2024-08-13 |  | Release date: | 2025-04-09 |  | Method: | ELECTRON MICROSCOPY (2.71 Å) |  | Cite: | Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment. Nat Commun, 16, 2025
 
 | 
 | 
| 9GGY 
   
  | | Human KRas4A (GDP) in complex with compound 29 |  | Descriptor: | 1,2-ETHANEDIOL, 12-(1-aza-5-azanidaspiro[4.5]decan-8-yl)-18-[(1-chloro-3-hydroxy-1,2,3-benzothiadiazol-5-yl)-lambda4-sulfanylidene]-4-hydroxy-3,3-dioxo-3lambda6-thia-1,4,12,17-tetraza-2lambda6-thia-6,10,19-triaza-3, GTPase KRas, ... |  | Authors: | Schuettelkopf, A.W. |  | Deposit date: | 2024-08-14 |  | Release date: | 2025-04-16 |  | Last modified: | 2025-05-21 |  | Method: | X-RAY DIFFRACTION (1.266 Å) |  | Cite: | Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras. J.Med.Chem., 68, 2025
 
 | 
 | 
| 5EZP 
   
  | | Human transthyretin (TTR) complexed with 4-hydroxy-chalcone |  | Descriptor: | 1,2-ETHANEDIOL, 4-hydroxy-chalcone, Transthyretin |  | Authors: | Polsinelli, I,  Nencetti, S,  Shepard, W.E,  Orlandini, E,  Stura, E.A. |  | Deposit date: | 2015-11-26 |  | Release date: | 2016-01-27 |  | Last modified: | 2024-01-10 |  | Method: | X-RAY DIFFRACTION (2.5 Å) |  | Cite: | A new crystal form of human transthyretin obtained with a curcumin derived ligand. J.Struct.Biol., 194, 2016
 
 | 
 | 
| 5M0D 
   
  | | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors |  | Descriptor: | CALCIUM ION, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, GLYCEROL, ... |  | Authors: | Keune, W.-J,  Heidebrecht, T,  Perrakis, A. |  | Deposit date: | 2016-10-04 |  | Release date: | 2017-08-16 |  | Last modified: | 2024-11-20 |  | Method: | X-RAY DIFFRACTION (2.4 Å) |  | Cite: | Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators. J. Med. Chem., 60, 2017
 
 | 
 | 
| 1ZE7 
   
  | | Zinc-binding domain of Alzheimer's disease amyloid beta-peptide in water solution at pH 6.5 |  | Descriptor: | 16-mer from Alzheimer's disease amyloid Protein |  | Authors: | Zirah, S,  Kozin, S.A,  Mazur, A.K,  Blond, A,  Cheminant, M,  Segalas-Milazzo, I,  Debey, P,  Rebuffat, S. |  | Deposit date: | 2005-04-18 |  | Release date: | 2005-05-03 |  | Last modified: | 2024-11-13 |  | Method: | SOLUTION NMR |  | Cite: | Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging. J.Biol.Chem., 281, 2006
 
 | 
 | 
| 3E6Q 
   
  | | Putative 5-carboxymethyl-2-hydroxymuconate isomerase from Pseudomonas aeruginosa. |  | Descriptor: | 1,2-ETHANEDIOL, ACETATE ION, FORMIC ACID, ... |  | Authors: | Osipiuk, J,  Xu, X,  Cui, H,  Savchenko, A,  Edwards, A.M,  Joachimiak, A,  Midwest Center for Structural Genomics (MCSG) |  | Deposit date: | 2008-08-15 |  | Release date: | 2008-08-26 |  | Last modified: | 2024-11-06 |  | Method: | X-RAY DIFFRACTION (1.75 Å) |  | Cite: | X-ray crystal structure of putative 5-carboxymethyl-2-hydroxymuconate isomerase from Pseudomonas aeruginosa. To be Published
 
 | 
 | 
| 3ULG 
   
  |  | 
| 5F58 
   
  |  | 
| 7AAK 
   
  | | Human porphobilinogen deaminase R173W mutant crystallized in the ES2 intermediate state |  | Descriptor: | 3-[4-(2-hydroxy-2-oxoethyl)-5-[[4-(2-hydroxy-2-oxoethyl)-5-[[4-(2-hydroxy-2-oxoethyl)-5-[[4-(2-hydroxy-2-oxoethyl)-3-(3-hydroxy-3-oxopropyl)-5-methyl-1~{H}-pyrrol-2-yl]methyl]-3-(3-hydroxy-3-oxopropyl)-1~{H}-pyrrol-2-yl]methyl]-3-(3-hydroxy-3-oxopropyl)-1~{H}-pyrrol-2-yl]methyl]-1~{H}-pyrrol-3-yl]propanoic acid, GLYCEROL, Porphobilinogen deaminase |  | Authors: | Kallio, J.P,  Bustad, H.J,  Martinez, A. |  | Deposit date: | 2020-09-04 |  | Release date: | 2021-02-17 |  | Last modified: | 2024-11-06 |  | Method: | X-RAY DIFFRACTION (1.7 Å) |  | Cite: | Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism. Iscience, 24, 2021
 
 | 
 | 
| 3UTU 
   
  | | High affinity inhibitor of human thrombin |  | Descriptor: | (2S)-N-[(4-carbamimidoylphenyl)methyl]-1-[(2S)-2-[(3-chloro-4-methoxybenzene)sulfonamido]-3-{[(4-cyanophenyl)methyl]carbamoyl}propanoyl]pyrrolidine-2-carboxamide, Hirudin variant-1, SODIUM ION, ... |  | Authors: | Baum, B,  Steinmetzer, T,  Heine, A,  Klebe, G. |  | Deposit date: | 2011-11-26 |  | Release date: | 2012-08-29 |  | Last modified: | 2024-11-20 |  | Method: | X-RAY DIFFRACTION (1.55 Å) |  | Cite: | Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling Chemmedchem, 7, 2012
 
 | 
 | 
| 3M7T 
   
  |  |